Cargando…
Malignant Myoepithelioma of the Head and Neck: Demographics, Clinicopathological Characteristics, Treatment, and Prognosis
Malignant myoepithelioma of the head and neck (HNMM) is a rare malignancy, and its characteristics and survival rates have not been well-defined. This study aimed to define the epidemiology of HNMM and identify the prognostic factors associated with the disease. Data on all patients diagnosed with H...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279609/ https://www.ncbi.nlm.nih.gov/pubmed/35847870 http://dx.doi.org/10.3389/fonc.2022.754967 |
_version_ | 1784746436283334656 |
---|---|
author | Wang, Jia-Qi Deng, Rong-Xin Liu, Hui Luo, Yuan Lu, Meng-Meng Yang, Zhi-Cheng |
author_facet | Wang, Jia-Qi Deng, Rong-Xin Liu, Hui Luo, Yuan Lu, Meng-Meng Yang, Zhi-Cheng |
author_sort | Wang, Jia-Qi |
collection | PubMed |
description | Malignant myoepithelioma of the head and neck (HNMM) is a rare malignancy, and its characteristics and survival rates have not been well-defined. This study aimed to define the epidemiology of HNMM and identify the prognostic factors associated with the disease. Data on all patients diagnosed with HNMM between 1991 and 2016 were gathered from the Surveillance Epidemiology and End Results (SEER) database. The demographics, clinicopathological characteristics, treatment, and prognoses of the patients were described. Cox regression analysis was used to identify the prognostic factors, and the prognostic nomograms for overall survival (OS) and disease-specific survival (DSS) were constructed. A total of 333 cases of HNMM were identified. The average age at diagnosis was 60.6 years, and 50.1% of the patients were men. After diagnosis, 46.2% of patients underwent surgery alone, 43.5% of patients underwent surgery and radiotherapy, and 3.6% of patients received only radiotherapy. Survival analysis showed that the 5-year OS and DSS for all HNMM patients were 69.7 and 82.1%, respectively. In the multivariate analysis model, the undifferentiated pathological grade (P <0.05) and M1 in the M category (P <0.01) were independent prognostic factors for poor OS and DSS, whereas the use of surgical resection was an independent favorable prognostic factor for both OS and DSS (P <0.05). The prognostic nomograms for OS and DSS prediction were constructed; the C-index values for OS and DSS prediction were 0.78 (95% CI 0.70–0.86) and 0.79 (95% CI 0.67–0.90), respectively. In conclusion, this SEER data-based study demonstrated that HNMM patients often had a favorable prognosis, and distant metastasis, pathological grade, and the use of surgery contributed to their survival. Furthermore, we developed a prognostic nomogram to predict OS and DSS for HNMM patients to aid physicians in the clinical management of this rare disease. |
format | Online Article Text |
id | pubmed-9279609 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-92796092022-07-15 Malignant Myoepithelioma of the Head and Neck: Demographics, Clinicopathological Characteristics, Treatment, and Prognosis Wang, Jia-Qi Deng, Rong-Xin Liu, Hui Luo, Yuan Lu, Meng-Meng Yang, Zhi-Cheng Front Oncol Oncology Malignant myoepithelioma of the head and neck (HNMM) is a rare malignancy, and its characteristics and survival rates have not been well-defined. This study aimed to define the epidemiology of HNMM and identify the prognostic factors associated with the disease. Data on all patients diagnosed with HNMM between 1991 and 2016 were gathered from the Surveillance Epidemiology and End Results (SEER) database. The demographics, clinicopathological characteristics, treatment, and prognoses of the patients were described. Cox regression analysis was used to identify the prognostic factors, and the prognostic nomograms for overall survival (OS) and disease-specific survival (DSS) were constructed. A total of 333 cases of HNMM were identified. The average age at diagnosis was 60.6 years, and 50.1% of the patients were men. After diagnosis, 46.2% of patients underwent surgery alone, 43.5% of patients underwent surgery and radiotherapy, and 3.6% of patients received only radiotherapy. Survival analysis showed that the 5-year OS and DSS for all HNMM patients were 69.7 and 82.1%, respectively. In the multivariate analysis model, the undifferentiated pathological grade (P <0.05) and M1 in the M category (P <0.01) were independent prognostic factors for poor OS and DSS, whereas the use of surgical resection was an independent favorable prognostic factor for both OS and DSS (P <0.05). The prognostic nomograms for OS and DSS prediction were constructed; the C-index values for OS and DSS prediction were 0.78 (95% CI 0.70–0.86) and 0.79 (95% CI 0.67–0.90), respectively. In conclusion, this SEER data-based study demonstrated that HNMM patients often had a favorable prognosis, and distant metastasis, pathological grade, and the use of surgery contributed to their survival. Furthermore, we developed a prognostic nomogram to predict OS and DSS for HNMM patients to aid physicians in the clinical management of this rare disease. Frontiers Media S.A. 2022-06-30 /pmc/articles/PMC9279609/ /pubmed/35847870 http://dx.doi.org/10.3389/fonc.2022.754967 Text en Copyright © 2022 Wang, Deng, Liu, Luo, Lu and Yang https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Wang, Jia-Qi Deng, Rong-Xin Liu, Hui Luo, Yuan Lu, Meng-Meng Yang, Zhi-Cheng Malignant Myoepithelioma of the Head and Neck: Demographics, Clinicopathological Characteristics, Treatment, and Prognosis |
title | Malignant Myoepithelioma of the Head and Neck: Demographics, Clinicopathological Characteristics, Treatment, and Prognosis |
title_full | Malignant Myoepithelioma of the Head and Neck: Demographics, Clinicopathological Characteristics, Treatment, and Prognosis |
title_fullStr | Malignant Myoepithelioma of the Head and Neck: Demographics, Clinicopathological Characteristics, Treatment, and Prognosis |
title_full_unstemmed | Malignant Myoepithelioma of the Head and Neck: Demographics, Clinicopathological Characteristics, Treatment, and Prognosis |
title_short | Malignant Myoepithelioma of the Head and Neck: Demographics, Clinicopathological Characteristics, Treatment, and Prognosis |
title_sort | malignant myoepithelioma of the head and neck: demographics, clinicopathological characteristics, treatment, and prognosis |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9279609/ https://www.ncbi.nlm.nih.gov/pubmed/35847870 http://dx.doi.org/10.3389/fonc.2022.754967 |
work_keys_str_mv | AT wangjiaqi malignantmyoepitheliomaoftheheadandneckdemographicsclinicopathologicalcharacteristicstreatmentandprognosis AT dengrongxin malignantmyoepitheliomaoftheheadandneckdemographicsclinicopathologicalcharacteristicstreatmentandprognosis AT liuhui malignantmyoepitheliomaoftheheadandneckdemographicsclinicopathologicalcharacteristicstreatmentandprognosis AT luoyuan malignantmyoepitheliomaoftheheadandneckdemographicsclinicopathologicalcharacteristicstreatmentandprognosis AT lumengmeng malignantmyoepitheliomaoftheheadandneckdemographicsclinicopathologicalcharacteristicstreatmentandprognosis AT yangzhicheng malignantmyoepitheliomaoftheheadandneckdemographicsclinicopathologicalcharacteristicstreatmentandprognosis |